Article Details

Bicycle Therapeutics (NASDAQ:BCYC) Rating Increased to Buy at Goldman Sachs Group

Retrieved on: 2019-09-10 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Bicycle Therapeutics (NASDAQ:BCYC) Rating Increased to Buy at Goldman Sachs Group. View article details on HISWAI:

Excerpt

<div>Finally, <b>Atlas Venture</b> Advisors Inc. bought a new position in Bicycle Therapeutics during the second quarter valued at about $13,709,000. Institutional ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up